Omega Healthcare Investors, Inc.

Omega Healthcare Investors, Inc. (OHI) Market Cap

Omega Healthcare Investors, Inc. has a market capitalization of $15.14B.

Price: $50.63

0.23 (0.46%)

Market Cap: 15.14B

NYSE · time unavailable

CEO: C. Taylor Pickett

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1992-08-07

Website: https://www.omegahealthcare.com

Omega Healthcare Investors, Inc. (OHI) - Company Information

Market Cap: 15.14B|Sector: Real Estate

Company Profile

Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A diverse array of healthcare operators manage these assets, predominantly utilizing a triple-net lease framework. Its portfolio is geographically distributed across all regions of the United States and also includes holdings in the United Kingdom.

Analyst Sentiment

60%
Buy

From 20 Active Polls

1Y Forecast: $50.57

▼ -0.1% Potential Upside

Consensus Target Metrics

Low Bound

$47

Median

$50

High Bound

$56

Average

$51

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$50.57
▼ -0.12% Upside
Low Target
$47.00
-7% Risk
Median Target
$50.00
-1% Mid
High Target
$56.00
11% Max
Consensus
Hold
7 / 28 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)15,14414,24913,01713,14112,49010,67210,77710,38310,693
Enterprise Value ($M)19,12418,22917,43217,37016,74714,93814,85614,70315,208
Price to Earnings Ratio (P/E)17.529.8523.3119.1116.7519.9228.0023.0823.66
Price/Earnings-to-Growth Ratio (PEG)2.5165.915.821.639.6419.362.57
Price to Sales Ratio (P/S)11.7242.4540.3040.8340.0837.7838.9437.1738.74
Price to Book Ratio (P/B)2.812.642.512.542.482.142.272.292.54
Price to Free Cash Flow Ratio (P/FCF)16.7663.8761.9456.9852.1547.0566.1449.0560.00
Enterprise Value to Sales (EV/Sales)54.3153.9853.9853.7552.8853.6752.6455.10
Enterprise Value to EBITDA (EV/EBITDA)13.2035.4559.3356.2750.5153.2460.2158.2362.51
Debt to Equity Ratio2.750.750.860.820.991.000.941.071.15

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 OMEGA HEALTHCARE INVESTORS REIT IN (OHI) — Investment Overview

🧩 Business Model Overview

OMEGA HEALTHCARE INVESTORS REIT IN (“OHI”) owns healthcare real estate—primarily post-acute and senior-care properties—and monetizes it by leasing facilities to healthcare operators under long-duration lease structures. The core value chain is straightforward: acquire/own income-producing properties → underwrite operator demand and credit quality → structure lease terms (often including rent escalators and tenant protections) → collect recurring rent (and, where applicable, related income streams) supported by the underlying need for care services.

Operator relationships and lease terms create practical stickiness: replacement of a landlord is operationally difficult for operators because it requires re-syndication of financing, re-papering of facilities, and renegotiation of property-level economics—making OHI’s cash flows comparatively resilient to day-to-day fluctuations in care utilization.

💰 Revenue Streams & Monetisation Model

OHI’s monetisation is primarily recurring rental income from leased properties. The economic engine is the spread between (i) the cash flows generated by operating facilities under lease and (ii) OHI’s fixed/managed costs of capital and property ownership.

  • Base rent from long-term leases: the dominant recurring component; supports predictable underwriting assumptions.
  • Rent structure and escalators: many lease frameworks incorporate built-in rent growth, which can help offset inflationary pressures over time.
  • Secondary income components (where structured): additional income may arise from ancillary lease features and property-level arrangements.

For margin, the key drivers are: (1) occupancy and operator performance through the lease term, (2) lease protections and escalation mechanics, and (3) the ability to re-lease or reposition properties when operator circumstances change.

🧠 Competitive Advantages & Market Positioning

OHI’s moat is best characterized as lease-based switching costs plus credit-and-underwriting discipline. Competitors can assemble portfolios, but durable share gains are constrained by the difficulty of underwriting operator risk, structuring lease protections, and maintaining a resilient tenant mix through credit cycles.

  • Switching costs / contracted landlord-client economics: long-duration lease structures and property-specific arrangements reduce the ability of operators to “shop” landlord terms without material operational and financial disruption.
  • Integrated ecosystem with operators: OHI’s value depends on a repeatable approach to operator selection, ongoing monitoring, and lease structuring—an institutional capability that is difficult for new entrants to replicate quickly.
  • Credit culture and underwriting bar: in healthcare real estate, tenant solvency and reimbursement sensitivity are central; disciplined underwriting can reduce impairment risk and stabilize AFFO-like cash generation.

COMPETITIVE BENCHMARKING: OHI primarily competes with other healthcare REITs such as Welltower (WELL), Healthpeak (PEAK), and Ventas (VTR).

  • Welltower (WELL): more oriented toward senior housing and care models, with different operator mixes and property economics.
  • Healthpeak (PEAK): more focused on medical office and life-science adjacent real estate rather than predominantly post-acute care facility economics.
  • Ventas (VTR): broader healthcare footprint across seniors and healthcare settings, with varying lease dynamics and reimbursement sensitivities.

Compared with these peers, OHI’s market positioning emphasizes post-acute facility exposure and the underwriting/lease mechanics required to manage operator and reimbursement risk.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, OHI’s investment case is supported by demographic demand for post-acute and senior care, alongside structural factors that influence supply and pricing power in healthcare real estate.

  • Aging demographics and care intensity: growth in the population requiring post-acute services increases the long-term need for dedicated care capacity.
  • Under-supply and redevelopment cycles: healthcare facilities require capital-intensive maintenance and regulatory compliance; aging stock and modernization needs can support pricing power for well-positioned properties.
  • Operator consolidation and lease continuity: consolidation among providers can improve underwriting visibility for landlords with experienced credit frameworks, supporting lease stability.
  • Rent escalators and contract structures: lease design can translate care-demand resilience into steadier landlord cash flows through the contract period.

⚠ Risk Factors to Monitor

  • Regulatory and reimbursement risk: Medicare/Medicaid payment dynamics can directly affect operator cash flow and, by extension, rent coverage and lease performance.
  • Tenant credit and impairment risk: weakened operator balance sheets can lead to rent disputes, restructurings, or property-level impairments.
  • Re-leasing and property obsolescence: facility requirements, staffing models, and care delivery standards evolve; repositioning may be capital intensive.
  • Interest rate and refinancing risk: REIT capital structures are sensitive to financing conditions, affecting cost of debt and the ability to fund acquisitions or development.
  • Concentration risk: geographic and operator concentration can magnify downside if local reimbursement or economic conditions deteriorate.

📊 Valuation & Market View

The market for healthcare REITs typically values companies based on cash-flow quality rather than purely earnings optics. Common valuation sensitivities include:

  • AFFO/cash-flow yield and sustainability: the durability of tenant rent and the risk-adjusted path to growth.
  • Portfolio cap rates and mark-to-market sentiment: property-level pricing expectations influence valuation through cap rate spreads.
  • Lease structure attributes: duration, escalation terms, and loss-mitigation protections can move perceived risk and therefore valuation multiples.
  • Credit outlook for tenants: underwriting credibility and impairment history affect how investors discount future cash flows.

Key valuation drivers are therefore less about short-term earnings and more about long-duration cash flow visibility, tenant health, and property-level replacement economics.

🔍 Investment Takeaway

OHI’s long-term thesis rests on lease-based cash-flow durability supported by credit-aware underwriting and operator-specific switching frictions. While reimbursement regulation and tenant solvency remain the principal risks, the company’s competitive positioning emphasizes institutional capabilities in lease structuring and property management—factors that can help sustain risk-adjusted cash generation through healthcare cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for OHI.

marketbeat.com2026-07-31

Omega Healthcare Investors Q2 Earnings Call Highlights

Omega Healthcare Investors NYSE: OHI reported second-quarter 2026 results marked by higher revenue, a large gain from asset sales, improved portfolio coverage and an increased full-year Adjusted FFO outlook, while management outlined plans for greater investment activity in the second half of the year.

seekingalpha.com2026-07-30

Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript

Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript

seekingalpha.com2026-07-30

Omega Healthcare Investors: The Silver Tsunami Now Looks Priced In (Rating Downgrade)

Omega Healthcare Investors is now rated Hold as its valuation aligns with fair value, reflecting a balanced risk-reward profile. OHI's SHOP/RIDEA operational pivot positions it to capture upside from demographic tailwinds but introduces greater operational risk and volatility. Q2 results showed AFFO up 12.55% YoY, a dividend increase after years of pause, and upgraded 2026 AFFO guidance to $3.22–$3.26 per share.

zacks.com2026-07-29

Omega Healthcare Investors (OHI) Q2 FFO and Revenues Beat Estimates

Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.77 per share a year ago.

businesswire.com2026-07-29

Omega Reports Second Quarter 2026 Results and Recent Developments

HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended June 30, 2026. SECOND QUARTER 2026 AND RECENT HIGHLIGHTS Net income for the quarter of $380 million, or $1.19 per diluted share, compared to $140 million, or $0.46 per diluted share, for Q2 2025. Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of $261 million, or $0.83 per diluted share, on 316 million weighted-ave.

businesswire.com2026-07-23

Omega Announces Increase in Quarterly Dividend

HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.68 per share, increasing the quarterly dividend on its common stock by $0.01 per share over the previous quarter. The dividend is payable Friday, August 14, 2026, to common stockholders of record as of the close of business on Monday, August 3, 2026.Taylor Pickett, Omega's Chief Executive Officer, stated, “We are pleased to announce a.

zacks.com2026-07-23

GLPI vs. OHI: Which Stock Is the Better Value Option?

Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Gaming and Leisure Properties (GLPI) and Omega Healthcare Investors (OHI). But which of these two stocks offers value investors a better bang for their buck right now?

defenseworld.net2026-07-22

D.A. Davidson & CO. Has $1.70 Million Stake in Omega Healthcare Investors, Inc. $OHI

D.A. Davidson and CO. raised its holdings in Omega Healthcare Investors, Inc. (NYSE: OHI) by 131.8% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 38,750 shares of the real estate investment trust's stock after purchasing an additional 22,030 shares during the

defenseworld.net2026-07-22

Omega Healthcare Investors, Inc. $OHI Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System trimmed its position in shares of Omega Healthcare Investors, Inc. (NYSE: OHI) by 7.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 746,962 shares of the real estate investment trust's stock after selling 63,429 shares during

seekingalpha.com2026-07-16

Omega Healthcare: Structurally Advantaged With A Near 6% Yield

Omega Healthcare (OHI) is a structurally advantaged healthcare REIT focused on skilled nursing and senior-care facilities, rated Buy for double-digit AFFO growth prospects. OHI benefits from an aging population, diversified operator base, and long lease terms, positioning it for sustained demand and rental income growth. Recent AFFO guidance was raised, with Q2 expectations for a 9% y/y AFFO/share increase and a consistent track record of modest quarterly beats.

seekingalpha.com2026-07-10

Start Investing At 60 And Retire On Dividends Forever

Retiring on dividends remains achievable for late starters by building a high-yield, quality portfolio targeting a 6% yield with safe, growing payouts. Dividend-focused strategies mitigate sequence of returns risk, enabling investors to live off income rather than depleting principal during market downturns. Examples like Enbridge Inc. (ENB), Omega Healthcare Investors, Inc. (OHI), and Bristol-Myers Squibb Company (BMY) illustrate our buy low, sell high, and get paid to wait principles, delivering strong returns and dividend growth.

zacks.com2026-07-07

Omega Healthcare Investors (OHI) Upgraded to Buy: Here's What You Should Know

Omega Healthcare Investors (OHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com2026-07-06

Healthcare REITs in Focus as a Long-Term Bet on Aging Demographics

Healthcare REITs like Welltower are benefiting from aging demographics, rising senior housing demand and improving occupancy as new supply stays constrained.

businesswire.com2026-07-02

Omega Announces Second Quarter Earnings Release Date and Conference Call

HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended June 30, 2026, on Wednesday, July 29, 2026, after market close. In conjunction with its release, Omega will conduct a conference call on Thursday, July 30, 2026, at 10 a.m. Eastern Time to review its 2026 second quarter results and current developments. Investors and other interested parties may access the conference call in th.

zacks.com2026-06-29

PINE vs. OHI: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Alpine Income (PINE) or Omega Healthcare Investors (OHI). But which of these two stocks is more attractive to value investors?

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"OHI reported Q1’26 results with revenue of $323.0M and net income of $165.0M (EPS data shown as 0 in the fundamentals feed). On a YoY basis, revenue rose to $323.0M from $276.8M in Q1’25 (+16.7%), and net income increased to $165.0M from $109.0M in Q1’25 (+51.3%). QoQ, revenue was up slightly from $282.5M in Q2’25 to $323.0M in Q1’26 (+14.3%), and net income was roughly stable versus Q4’25 ($164.7M, +0.2%). Profitability appears strong: net profit margin was ~51.1% in Q1’26, slightly higher than Q4’25 (~51.2% essentially flat) and materially higher than Q1’25 (~39.4%), indicating margin expansion across the last four quarters. Operating income was $293.4M with an operating margin of ~90.8%, while interest expense remained high ($49.8M), consistent with leverage typical of healthcare REIT structures. Cash flow quality is solid in Q1’26: operating cash flow was $215.5M and free cash flow was $215.5M. Dividends paid were $198.4M, implying payout pressure (dividend payout ratio ~1.20 in the ratios table), but coverage remains supported by operating cash flow. Shareholder returns are positive with price up 22.25% over the last year, and a dividend yield of ~1.5% in the latest ratio set, supporting total return. Analyst consensus targets (median ~$48, consensus ~$49) sit below the current price, implying limited upside per valuation framing."

Revenue Growth

Positive

Revenue increased 16.7% YoY (Q1’25 $276.8M to Q1’26 $323.0M) and was up 14.3% vs Q2’25 ($282.5M to $323.0M), showing a positive growth trajectory across the period.

Profitability

Good

Net margin expanded to ~51.1% in Q1’26 from ~39.4% in Q1’25, with net income up 51.3% YoY. Profitability was broadly stable QoQ versus Q4’25 net income (+0.2%), indicating sustained earnings power.

Cash Flow Quality

Positive

Q1’26 operating cash flow was $215.5M with free cash flow of $215.5M. Dividends paid were $198.4M and the implied payout ratio was ~1.20, suggesting dividends slightly exceed earnings in coverage terms, but cash generation supports the payout.

Leverage & Balance Sheet

Neutral

Balance sheet shows very large assets ($9.40B total assets) and equity stability at ~$5.45B total equity. However, cash fell sharply by Q1’26 versus prior quarters while debt/liquidity dynamics are opaque here because total debt is not provided for the latest quarter; leverage risk is therefore moderate/uncertain.

Shareholder Returns

Good

Price gained 22.25% over 1 year (strong momentum >20%). With dividend yield ~1.5% indicated by ratios, total shareholder return appears favorable despite payout coverage near/above 100%.

Analyst Sentiment & Valuation

Fair

Consensus price target (~$49.14) and median target (~$48) are below the current price (~$46.82 in the provided market performance block), implying limited upside per the supplied valuation targets and a neutral-to-slightly cautious sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

OHI’s Q2 2026 performance was dominated by transaction-driven GAAP gains, but management used the quarter to highlight an execution engine: (1) monetizing troubled or credit-weakened tenants (CommuniCare) at an effective 6.7% cap rate, (2) improving portfolio credit through proactive transitions away from Ciena to Saber/HHC without cited negative FAD impact, and (3) scaling higher-return structures (RIDEA and OpCo/Propco JV pathways) with stabilized unlevered return targets (low-double digits for triple-net; low-to-mid teens for RIDEA). Financially, AFFO of $0.83/share and FAD of $0.78/share reflected strong year-over-year growth, while sequential AFFO was supported by net income from new investments and partially offset by revenue reduction tied to large asset sales/loan repayments (a near-term timing headwind expected to carry into Q3). Balance sheet flexibility improved materially via revolver paydown and continued liquidity, while full-year adjusted FFO guidance was raised and tightened to $3.22–$3.26.

AI IconGrowth Catalysts

  • New investments closed: $218m in Q2 (total $470m YTD) across U.S. skilled nursing, U.K. care homes, and senior housing operating portfolio (SHOP)
  • Expected stabilized unlevered returns: low-double-digits for triple-net deals and low-to-mid-teens for RIDEA deals
  • Operational portfolio improvements via triple-net/RIDEA growth and same-store financial performance (OpCo JV and Propco JV)

Business Development

  • Saber: major ship to #1; Saber OpCo/PropCo JV activity including $160m acquisition of 9 skilled nursing facilities in the Laurels portfolio (Omega 49% equity interest in Saber Propco JV; no additional equity needed by Saber or Omega)
  • HHC (current operator): $20m U.K./RIDEA conversion mention is separate; operational transition included 1 Ciena facility to the HHC master lease
  • CommuniCare: strategic exit of 18 facilities (Maryland and West Virginia) sold for $480m and rent discount ~7.7% to improve credit profile
  • Ciena: transitioned 20 facilities to Saber and HHC; later exited Ciena’s Laurels leased portfolio via transitions (18 to Saber master lease, 1 to HHC master lease) and sale of 1 facility to Saber Propco JV; Ciena also agreed to exit 8 owned Laurel assets to Saber Propco JV
  • Genesis bankruptcy: buyer to assume Omega Genesis master lease at same economic terms; expected term loan and DIP loan satisfaction from debtors’ consideration

AI IconFinancial Highlights

  • Revenue: $328m vs $283m in Q2 2025 (YOY increase driven by timing/impact of net new investments, annual escalators, and active portfolio management)
  • Net income available to common: $363m or $1.19/share (vs $137m or $0.46/share) driven by $247m gain on asset sales (primarily sale of 18 CommuniCare facilities)
  • Adjusted FFO: $261m or $0.83/share; FAD: $248m or $0.78/share
  • AFFO sequentially up ~+$0.25 vs Q1; incremental drivers: incremental net income from $377m new investments; $1.6m annual escalators; ~$1.6m lower net interest expense from credit facility paydowns; offsets: reduced revenue tied to $597m asset sales and $209m loan repayments, reducing Q2 AFFO by $7.5m
  • Operator coverage improvement: trailing 12-month operator EBITDAR coverage to 1.65x (as of March 31, 2026) from 1.58x in Q4 2025
  • Strategic sale pricing: CommuniCare assets sold at effective 6.7% cap rate on cash flow
  • Guidance update: full-year 2026 adjusted FFO range raised/tightened to $3.22–$3.26/share (midpoint $3.24), +$0.02 vs prior April midpoint; guidance assumes ~10m quarterly revenue impact from assets sold/loans repaid late in Q2 and ~$0.01 dividend increase

AI IconCapital Funding

  • Revolver: paid down $2.0bn revolver to $6m borrowings during quarter; supported by ~$700m proceeds from asset sales and loan repayments
  • Liquidity (June 30, 2026): $39m available cash and $145m restricted cash; $118m restricted cash held as sales proceeds/1031 exchange funds
  • Next scheduled debt maturity: April 2027
  • Fixed charge coverage: 6.5x at quarter end; leverage: 3.3x

AI IconStrategy & Ops

  • Genesis update: received $16m paydown on $25m superpriority secured DIP loan, reducing DIP balance to $90m; closing expected by end of year with master lease economics assumed by buyer
  • Portfolio credit improvement via transitions: moved 20 Ciena facilities to Saber and HHC; no negative FAD impact cited for the transaction
  • Ciena exit mechanics: transitioned 18 of 20 Laurels leased facilities to Saber master lease and 1 to HHC master lease; sold 1 facility to Saber Propco JV; Ciena also agreed to sell 8 owned Laurel assets to Saber Propco JV
  • RIDEA expansion: acquired 4 Omega-owned U.K. care homes operations for $20m and converted to RIDEA structure (first RIDEA investment in the U.K.; not due to operator issues)
  • CapEx comment: company referenced increased CapEx deployment for remainder of year and into 2027 (details not quantified in provided transcript)

AI IconMarket Outlook

  • Full-year 2026 adjusted FFO guidance: $3.22–$3.26/share (midpoint $3.24)
  • Guidance includes impact of investments closed as of July 29 and excludes any other investments not outlined in the earnings release
  • Guidance assumptions: $144m mortgages and other real estate loans scheduled to mature in 2026—$56m expected to convert to fee simple; remainder repaid
  • Non-real estate backed loans: $180m expected to be repaid throughout 2026, including ~$148m Genesis loans expected to be repaid at conclusion of bankruptcy process
  • Portfolio pruning: potential $15m–$25m per quarter in asset sales

AI IconRisks & Headwinds

  • Near-term earnings headwind from Q2 asset-sale and loan-repayment timing: $563m asset sales mentioned (early sequential headwind; expected to impact Q3 as well)
  • Staffing/macro: nursing home workforce recovery noted; risk remains that staffing may not keep pace with demographic demand (industry lost 14% workforce vs prepandemic; recovered by June 2026)
  • Regulatory/fraud: CMS risk-based survey process to roll out later in 2026; HHS/CMS focus on fraud and abuse may create indirect impacts if state budget constraints worsen (to date, none reported)
  • No major operator watchlist concerns per management, but company emphasized active offense/defense portfolio management as needed

Q&A: Analyst Interest

  • U.K. OpCo structure shift: Why previously high EBITDAR coverage (2.4x) led to moving toward/transitioning into triple-net or RIDEA—management said the operator monetized value, and OHI structured price/timing to deliver “outsized” returns above low-to-mid teens while reducing operator risk and strengthening long-term alignment.
  • RIDEA incentive/promote economics: Analyst asked whether OHI’s RIDEA promote structure evolves as RIDEA becomes a larger NOI share (e.g., typical “~5% of revenue” industry norms). Management emphasized they did not focus on industry comparisons; they spent time modeling promote structures to align interests and rely on buying good assets at decent prices.
  • SHOP growth/operating readiness: Analyst requested explicit SHOP target size and how OHI operationally prepares (technology/AI/data). Management declined quantity guidance because opportunities are uncertain and SHOP is “just getting started.” They cited hiring from Wall Street and industry operations, extending data analysis/AI capabilities, expanding accounting/back-office capacity, and scaling headcount as needed.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the OHI Q2 2026 (ended June 30, 2026) earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for OHI.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (OHI)

© 2026 Stock Market Info — Omega Healthcare Investors, Inc. (OHI) Financial Profile